Staar Surgical CoSTAA -5.48%79 Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates STAA with a GF Score™ of 79/100 and a GF Value™ of $31.39 (Fairly Valued). The stock has 7 warning signs investors should review. Among 316 Medical Devices & Instruments companies, Staar Surgical Co ranks worse than 316455.38% on this metric.
As of today (2026-06-26), the Forward Annual Dividend Yield of Staar Surgical Co is 0.00%.
As of today (2026-06-26), the Trailing Annual Dividend Yield of Staar Surgical Co is 0.00%.
STAA's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.09 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Staar Surgical Co (NAS:STAA) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Staar Surgical Co Forward Dividend Yield % Related Terms
STAA vs NNNN, ATRC, PLSE: Forward Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Staar Surgical Co (STAA) has a Forward Dividend Yield % of 0.00% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Staar Surgical Co and its competitors. According to the industry distribution chart, Staar Surgical Co ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is Staar Surgical Co's Forward Dividend Yield % too high?
Staar Surgical Co's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Staar Surgical Co ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Staar Surgical Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's Forward Dividend Yield % compare to NNNN and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #999999 out of 316 companies for Forward Dividend Yield %. This places Staar Surgical Co in the lower half of its industry. The industry median Forward Dividend Yield % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.09, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Staar Surgical Co and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Fairly Valued. The stock's GF Value™ is $31.39, compared to a current price of $29.50 — trading 6% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Staar Surgical Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $29.50 is trading 6% below its estimated GF Value™ of $31.39.
GuruFocus considers Staar Surgical Co to be Fairly Valued.
Key valuation signals for STAA:
Forward Dividend Yield %: 0.00%
GF Value™: $31.39 vs. price of $29.50 (6% below fair value)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
79GF Score
Get the complete analysis for STAA
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 